How FLT3 signaling affects leukemia development
Regulation of FLT3 Signaling in Leukemia
This study is looking at how changes in a specific protein called FLT3 affect the behavior of acute myeloid leukemia (AML) and aims to find new ways to help patients by fixing these changes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10916444 on NIH RePORTER |
What this research studies
This research investigates the role of FLT3 signaling in acute myeloid leukemia (AML) by examining how post-translational modifications, particularly palmitoylation, influence the behavior of FLT3 proteins. The study aims to understand how mutations in FLT3 lead to abnormal signaling pathways that contribute to leukemia progression. By disrupting the palmitoylation of oncogenic FLT3 mutants, researchers hope to redirect these proteins to their proper locations within the cell, potentially altering their signaling and impact on leukemia. This approach could provide insights into new therapeutic strategies for AML patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with acute myeloid leukemia, particularly those with FLT3 mutations.
Not a fit: Patients with other types of leukemia or those without FLT3 mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve outcomes for patients with acute myeloid leukemia.
How similar studies have performed: Other research has shown promising results in targeting signaling pathways in leukemia, suggesting that this approach may also yield significant findings.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Tong, Wei — Children's Hosp of Philadelphia
- Study coordinator: Tong, Wei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.